Ethylene Glycol

Ethylene Glycol

SCHEMBL1278216

CCCCCCCCCCCCCCCCC(O)C(=O)O.CCCCCCCCCCCCCCCCC(O)C(=O)O.OCCO

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 7/20 0.88
▸ FFAR1 O14842 2/20 0.88
▸ MAPT P10636 1/20 0.53
▸ LCK P06239 1/20 0.53
▸ PPARD Q03181 1/20 0.53
▸ ZDHHC20 Q5W0Z9 1/20 0.53
▸ ZDHHC2 Q9UIJ5 1/20 0.53
▸ FFAR4 Q5NUL3 1/20 0.50
▸ ACE2 Q9BYF1 1/20 0.50
▸ GRIK1 P39086 1/20 0.46
▸ GRIK2 Q13002 1/20 0.46
▸ S1PR2 O95136 1/20 0.45
▸ S1PR4 O95977 1/20 0.45
▸ S1PR1 P21453 1/20 0.45
▸ S1PR3 Q99500 1/20 0.45
▸ LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL299577 1.00 GPR84 (0.88) GPR84FFAR1MAPTLCKPPARD
Propanol SCHEMBL8962521 0.96 GPR84 (0.88) GPR84FFAR1MAPTLCKPPARD
Octacosanol SCHEMBL28650358 0.94 GPR84 (0.84) GPR84FFAR1MAPTLCKPPARD
1,6-Hexanediol SCHEMBL8714304 0.94 GPR84 (0.84) GPR84FFAR1MAPTLCKPPARD
1,4-Butanediol SCHEMBL28152529 0.94 GPR84 (0.84) GPR84FFAR1MAPTLCKPPARD
Dodecanol SCHEMBL15663800 0.94 GPR84 (0.84) GPR84FFAR1MAPTLCKPPARD
Alcohol SCHEMBL28147971 0.94 GPR84 (0.91) GPR84FFAR1MAPTLCKPPARD
Alcohol SCHEMBL28203446 0.94 GPR84 (0.91) GPR84FFAR1MAPTLCKPPARD
Alcohol SCHEMBL8607559 0.94 GPR84 (0.91) GPR84FFAR1MAPTLCKPPARD
SCHEMBL7990074 0.94 GPR84 (1.00) GPR84FFAR1MAPTLCKPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11801323-B2 Absorbent article with philic anhydrous lotion THE PROCTER AND GAMBLE COMPANY (US) 2023-10-31 — — US disclosed
US-20210236685-A1 ABSORBENT ARTICLE WITH PHILIC ANHYDROUS LOTION PROCTER & GAMBLE (US) 2021-08-05 — — US disclosed
US-10912857-B2 Absorbent article with philic anhydrous lotion THE PROCTER & GAMBLE COMPANY (US) 2021-02-09 — — US disclosed
US-20180050126-A1 ABSORBENT ARTICLE WITH PHILIC ANHYDROUS LOTION PROCTER & GAMBLE (US) 2018-02-22 — — US disclosed
EP-2624870-B1 ABSORBENT ARTICLE WITH LOTION PROCTER & GAMBLE (US) 2018-01-17 — — EP disclosed
US-9808551-B2 Absorbent article with philic anhydrous lotion THE PROCTER & GAMBLE COMPANY (US) 2017-11-07 — — US disclosed
US-9669130-B2 Absorbent article with lotion THE PROCTER & GAMBLE COMPANY (US) 2017-06-06 — — US disclosed
EP-2624807-B1 ABSORBENT ARTICLE WITH ANHYDROUS LOTION PROCTER & GAMBLE (US) 2015-12-09 — — EP disclosed
US-20150094679-A1 ABSORBENT ARTICLE WITH PHILIC ANHYDROUS LOTION PROCTER & GAMBLE (US) 2015-04-02 — — US disclosed
US-8921640-B2 Absorbent article with philic anhydrous lotion THE PROCTER & GAMBLE COMPANY (US) 2014-12-30 — — US disclosed
EP-2624807-A2 ABSORBENT ARTICLE WITH PHILIC ANHYDROUS LOTION The Procter and Gamble Company (US) 2013-08-14 — — EP disclosed
EP-2624870-A1 ABSORBENT ARTICLE WITH LOTION The Procter and Gamble Company (US) 2013-08-14 — — EP disclosed
US-20120123365-A1 Absorbent Article with Philic Anhydrous Lotion THE PROCTER & GAMBLE COMPANY 2012-05-17 — — US disclosed
US-20120089110-A1 Absorbent Article with Lotion THE PROCTER & GAMBLE COMPANY 2012-04-12 — — US disclosed
WO-2012047990-A1 ABSORBENT ARTICLE WITH LOTION THE PROCTER & GAMBLE COMPANY (US) 2012-04-12 — — WO disclosed
WO-2012047986-A2 ABSORBENT ARTICLE WITH PHILIC ANHYDROUS LOTION THE PROCTER & GAMBLE COMPANY (US) 2012-04-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210236685-A1 ABSORBENT ARTICLE WITH PHILIC ANHYDROUS LOTION CUTA, AQP1, SLC35B2 GPR84 3734/4885FFAR1 2375/4885MAPT 705/4885
US-20120123365-A1 Absorbent Article with Philic Anhydrous Lotion SLC16A8, SLC16A7, SLC16A3 GPR84 2251/4885FFAR1 356/4885MAPT 2209/4885
US-11801323-B2 Absorbent article with philic anhydrous lotion CUTA, AQP1, SLC35B2 GPR84 3734/4885FFAR1 2375/4885MAPT 705/4885
US-20150094679-A1 ABSORBENT ARTICLE WITH PHILIC ANHYDROUS LOTION SLC16A8, SLC16A7, SLC16A3 GPR84 2251/4885FFAR1 356/4885MAPT 2209/4885
US-10912857-B2 Absorbent article with philic anhydrous lotion CUTA, AQP1, SLC35B2 GPR84 3734/4885FFAR1 2375/4885MAPT 705/4885
US-20180050126-A1 ABSORBENT ARTICLE WITH PHILIC ANHYDROUS LOTION CUTA, AQP1, SLC35B2 GPR84 3734/4885FFAR1 2375/4885MAPT 705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback